| Stage | XEL | % of rev | CNP | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $4.2B | 100.00% | $2.2B | 100.00% | XEL ×1.90 |
| Gross profit | $2.3B | 54.79% | $1.3B | 57.33% | CNP +2.5pp |
| Operating income | $1.2B | 28.55% | $667M | 30.44% | CNP +1.9pp |
| Pre-tax income | $1.0B | 24.66% | $413M | 18.85% | XEL +5.8pp |
| Net income | $960M | 23.01% | $331M | 15.11% | XEL +7.9pp |
| Stage | XEL | CNP | Gap · A − B |
|---|---|---|---|
| Revenue | $4.2B100.00% | $2.2B100.00% | XEL ×1.90 |
| Gross profit | 54.79%$2.3B | 57.33%$1.3B | CNP +2.5pp |
| Operating income | 28.55%$1.2B | 30.44%$667M | CNP +1.9pp |
| Pre-tax income | 24.66%$1.0B | 18.85%$413M | XEL +5.8pp |
| Net income | 23.01%$960M | 15.11%$331M | XEL +7.9pp |
No shared counterparties.